Methylene blue
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Methylene blue is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the treatment of Drug induced methemoglobinemia. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
Drug induced methemoglobinemia
Dosage
0.1 to 0.2 mL per kilogram of body weight (0.045 to 0.09 mL per pound of body weight). Inject Methylene Blue intravenously very slowly over a period of several minutes.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Methylene blue in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Methylene blue in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Methylene blue FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Methylene blue in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Methylene blue in pediatric patients.
Contraindications
Intraspinal injection is contraindicated.
Warnings
Methylene Blue should not be given by subcutaneous or intrathecal injection.
Adverse Reactions
Clinical Trials Experience
Large intravenous doses of Methylene Blue produce nausea, abdominal and precordial pain, dizziness, headache, profuse sweating, mental confusion and the formation of methemoglobin.
Postmarketing Experience
There is limited information regarding Methylene blue Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Methylene blue Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
Safety for use in pregnancy has not been established. Use of Methylene Blue in women of childbearing potential requires that anticipated benefits be weighed against possible hazards.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Methylene blue in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Methylene blue during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Methylene blue in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Methylene blue in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Methylene blue in geriatric settings.
Gender
There is no FDA guidance on the use of Methylene blue with respect to specific gender populations.
Race
There is no FDA guidance on the use of Methylene blue with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Methylene blue in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Methylene blue in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Methylene blue in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Methylene blue in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Methylene blue Administration in the drug label.
Monitoring
There is limited information regarding Methylene blue Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Methylene blue and IV administrations.
Overdosage
There is limited information regarding Methylene blue overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Methylene blue Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Methylene blue Mechanism of Action in the drug label.
Structure
There is limited information regarding Methylene blue Structure in the drug label.
Pharmacodynamics
There is limited information regarding Methylene blue Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Methylene blue Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Methylene blue Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Methylene blue Clinical Studies in the drug label.
How Supplied
Methylene Blue Injection, USP, 1% is supplied as follows:
NDC 17478-504-01 1 mL in 2 cc (partially filled) vials in packages of 10.
NDC 17478-504-10 10 mL vials in packages of 10.
The vials are packaged with a Flip Tear-Off Seal. The seal can either be flipped normally to reveal the rubber stopper or be totally removed so the rubber stopper can be taken out of the vial. The plastic button is attached to the metal seal, which when pulled, tears the seal at the score line allowing the metal portion to be removed.
Storage
STORAGE: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Images
Drug Images
{{#ask: Page Name::Methylene blue |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Methylene blue |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Methylene blue Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Methylene blue interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Methylene blue Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Methylene blue Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.